Health Europa, a publisher of digital content on Health issue sin Europe and beyond, published a feature about Ophiomics and HepatoPredict in its Health Europa Quarterly Issue.

Ophiomics was granted the SME Instrument Phase I grant to conduct a Feasibility study for its HepatoPredict genomic signature for Liver Cancer. Check here for the CORDIS page.  This grant will permit Ophiomics to build a business case for HepatoPredict.